Bajaj Consumer Care Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BAJAJCON, BSE:533229 Bajaj Consumer Care Ltd.

Bajaj Consumer Care Ltd.

29 May 2019

272.55

-0.37%

Bajaj Consumer Care Ltd

Buy: Bajaj Consumer Care Ltd.

Recommendation Target

CD Equisearch

Established to sell hair oils and other beauty products, Bajaj Consumer Care Ltd. is one of the leading players in the hair oil category with brands like Bajaj Almond Drops Hair oil. With the acquisition of Nomarks, they have also...

Bajaj Consumer Care has gained 52.68% in the last 6 Months

Bajaj Consumer Care Ltd.

10 Apr 2019

272.55

-0.37%

Bajaj Consumer

Results Update: Bajaj Consumer Care Ltd.

Dolat Capital

The company reported a topline growth of 10.9% in Q4FY19, driven by a 6% volume growth during the quarter. The company maintained its volume performance posted in Q3FY19. Despite RM inflation, the company was able to restrict margin fall to 80bps was encouraging considering 30%+ margins, highest margins in the consumer space. The ADHO brand, continues to gain volume and value market share. Strong volume growth in modern trade (+21%) and general trade (+11%) along with +56% growth in IB helped sales growth to accelerate during the quarter. However, 15%...

Bajaj Consumer Care has gained 52.68% in the last 6 Months

Bajaj Consumer Care Ltd.

23 Oct 2018

272.55

-0.37%

Bajaj Corp

Buy: Bajaj Consumer Care Ltd.

Target

JM Financial

Bajaj Corp reported a very subdued revenue performance in 2QFY19 with domestic volumes being flattish as per our workings .This is probably attributable to channel inventory clearance prior to the re-launch of its flagship Bajaj Almond Drops brand and some destocking in the rural wholesale channel. Management remains quite confident of delivering a sharp improvement in volume growth from next quarter onwards aided by higher media activation post re-launch of BAD and the festive season demand. Interestingly, as per Nielsen, retail offtakes grew in excess of 25% (of a weaker base though as volumes were merely 5% higher on a sequential basis) and BAD was able to further enhance market share in both...

Bajaj Consumer Care Ltd. is trading below its 30 day SMA of 275.0

Bajaj Consumer Care Ltd.

18 Jul 2018

272.55

-0.37%

Bajaj Corp Ltd: Strong Signs of Recovery in Rural Markets an...

Buy: Bajaj Consumer Care Ltd.

Recommendation Target

Karvy

Strong Signs of Recovery in Rural Markets and Stable Domestic Volumes to Support Top-line: Bajaj Corp has delivered a healthy revenue numbers during the quarter on the back of 13.9% growth in domestic volumes, led by 11.2% YoY growth in Almond Drops Hair Oil volume.

Bajaj Consumer Care has gained 28.88% in the last 1 Year

Bajaj Consumer Care Ltd.

16 Jul 2018

272.55

-0.37%

Bajaj Corp

Buy: Bajaj Consumer Care Ltd.

Target

Dolat Capital

Domestic business performance improved; IB was laggard A top-line growth of 9.5% could be attributed to a satisfactory 8.7% volume growth (on case basis) but was restricted by poor IB performance. Despite 20% YoY increase in LLP prices, GM improved 150bps driven by better sales mix. EBITDA margins also expanded by 50bps as GM expansion and 150bps decline in other expense was partially offset by 140/100bps increase in employee cost/A&P; spends during the quarter. We believe that favourable volume base will enhance performance going ahead. Further improvement in wholesale and CSD channels...

Bajaj Consumer Care Ltd. is trading above its 200 day SMA of 212.1

Bajaj Consumer Care Ltd.

13 Jul 2018

272.55

-0.37%

Bajaj Corp

Buy: Bajaj Consumer Care Ltd.

Target

JM Financial

Good quarter; volume trajectory now looking up Bajaj Corp reported a better than expected 1QFY19 earnings buoyed by a much stronger than expected acceleration in volume growth of its flagship Bajaj Almond Drops (BAD) to 11.2% - this is the highest seen in the last 13 quarters, albeit on an easy base (volumes fell 6.6% in 1Q last year due to GST-transition related downstocking by the trade). Domestic volume growth was even stronger at 13.9% and more importantly, retail-level offtakes, which are free of base and destocking-related issues, also grew 10.2% during the quarter. Management is, after quite a long time, sounding reasonably bullish about the business'...

Bajaj Consumer Care has gained 52.68% in the last 6 Months

Bajaj Consumer Care Ltd.

31 May 2018

272.55

-0.37%

Bajaj Corp Ltd: Sluggish Recovery in Rural Volumes, Stable D...

Hold: Bajaj Consumer Care Ltd.

Target

Karvy

Sluggish Recovery in Rural Volumes, Stable Domestic Volumes to Continue Further: Bajaj Corp has delivered steady revenue numbers during the quarter on the backof 5.9% growth in overall volumes, led by 7.3% (during Q4FY18) volume growth in Bajaj Almond Drops. The volume growth from rural areas has remained sluggish during the quarter.

Bajaj Consumer Care Ltd. is trading below its 30 day SMA of 275.0

Bajaj Consumer Care Ltd.

23 May 2018

272.55

-0.37%

Bajaj Corp Ltd

Accumulate: Bajaj Consumer Care Ltd.

Recommendation Target

CD Equisearch

nd establish itself as a full FMCG company. Increasing dependence on modern trade (more profitable than general trade) and initiatives to increase direct distribution would doubtlessly help the company to launch new products....

Bajaj Consumer Care has gained 28.88% in the last 1 Year

Bajaj Consumer Care Ltd.

16 Feb 2018

272.55

-0.37%

Bajaj Corp Ltd: Healthy Domestic Volumes and Further Growth ... (Feb 16, 2018)

Hold: Bajaj Consumer Care Ltd.

Target

Karvy

Healthy Domestic Volumes and Further Growth Expected on the Back of Rural Volumes: Bajaj Corp has delivered healthy revenue numbers during the quarter on the back of 5.2% growth in overall volumes, led by 8.3% growth in domestic hair oil brand volume. Volume growth from rural areas has remained weak due to the sluggish demand scenario.

Bajaj Consumer Care has gained 28.88% in the last 1 Year

Bajaj Consumer Care Ltd.

15 Jan 2018

272.55

-0.37%

Bajaj Corp

Buy: Bajaj Consumer Care Ltd.

Dolat Capital

A top-line growth of 5.9% could be attributed to a remarkable 8.2% volume growth in the domestic market but was restricted by a dip in CSD sales and in IB. Despite YoY increase in LLP prices, GM grew due to better sales mix. However, EBITDA margins dipped 10bps as a rise in GM was completely offset by 240/90/40bps increase in A&P;/employee/other expenses. We believe the volume base is very favorable which will enhance performance Q4FY18 onwards. Further, higher volume growth would present an opportunity to take price hikes in the near term. We have marginally tweaked...